{"organizations": [], "uuid": "e93fab38b199ab873685cdfd131c87ab9d48319c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-ipsen-announces-health-canada-appr/brief-ipsen-announces-health-canada-approval-of-dysport-therapeutic-for-treatment-of-lower-limb-spasticity-in-adults-idUSFWN1QX0P5", "country": "US", "domain_rank": 408, "title": "BRIEF-Ipsen Announces Health Canada Approval Of Dysport Therapeutic For Treatment Of Lower Limb Spasticity In Adults", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-15T14:14:00.000+02:00", "replies_count": 0, "uuid": "e93fab38b199ab873685cdfd131c87ab9d48319c"}, "author": "", "url": "https://www.reuters.com/article/brief-ipsen-announces-health-canada-appr/brief-ipsen-announces-health-canada-approval-of-dysport-therapeutic-for-treatment-of-lower-limb-spasticity-in-adults-idUSFWN1QX0P5", "ord_in_thread": 0, "title": "BRIEF-Ipsen Announces Health Canada Approval Of Dysport Therapeutic For Treatment Of Lower Limb Spasticity In Adults", "locations": [], "entities": {"persons": [{"name": "ipsen sa", "sentiment": "none"}, {"name": "ipsen", "sentiment": "none"}], "locations": [{"name": "canada", "sentiment": "none"}], "organizations": [{"name": "brief-ipsen announces health canada approval of dysport therapeutic for treatment of lower limb", "sentiment": "negative"}, {"name": "brief-ipsen announces health canada approval of dy", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "treatment of lower limb spasticity in adults reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 15, 2018 / 12:15 PM / Updated 7 minutes ago BRIEF-Ipsen Announces Health Canada Approval Of Dysport Therapeutic For Treatment Of Lower Limb Spasticity In Adults Reuters Staff 1 Min Read March 15 (Reuters) - Ipsen Sa: * IPSEN ANNOUNCES HEALTH CANADA APPROVAL OF DYSPORT THERAPEUTIC (ABOBOTULINUMTOXINA) FOR THE TREATMENT OF LOWER LIMB SPASTICITY IN ADULTS * IPSEN SA - HEALTH CANADA APPROVED DYSPORT THERAPEUTIC FOR SYMPTOMATIC TREATMENT OF FOCAL SPASTICITY AFFECTING LOWER LIMBS IN ADULTS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-15T14:14:00.000+02:00", "crawled": "2018-03-15T14:30:54.007+02:00", "highlightTitle": ""}